Role of human papillomaviruses in cancer of the respiratory and upper digestive tract

Clinics in Dermatology

Volumn 15, Issue 3, 1997, Pages 415-425

  Snijders, Peter J F ^a   Steenbergen, Renske D M ^a   Meijer, Chris J L M ^a   Walboomers, Jan M M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROLIFERATION; DIGESTIVE SYSTEM CANCER; ESOPHAGUS CARCINOMA; HEAD AND NECK CARCINOMA; HUMAN; LARYNX CARCINOMA; LUNG CARCINOMA; MOUTH CARCINOMA; PRIORITY JOURNAL; RESPIRATORY TRACT CANCER; REVIEW; TONSIL CARCINOMA; VIRUS CARCINOGENESIS; VIRUS STRAIN; WART VIRUS;

EID: 0030739439     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(96)00156-3     Document Type: Article

References (112)

1. Zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol 1994;186:131-56.
2. IARC working group. IARC monographs on the evaluation of carcinogenic risk to humans. Human papillomaviruses. Lyon: IARC Scientific Publications, 1995.
3. Yeudall WA. Human papillomaviruses and oral neoplasia. Oral Oncol Eur J Cancer 1992;28B:61-6.
4. Chang F, Syrjänen S, Wang L, et al. Infectious agents in the etiology of esophageal cancer. Gastroenterology 1992;103:1336-48.
5. Chang F, Wang L, Syrjänen S, et al. Human papillomavirus infections in the respiratory tract. Am J Otolaryngol 1992;13:210-25.
6. Snijders PJF, Van den Brule AJC, Meijer CJLM, et al. Papillomaviruses and cancer of the upper digestive and respiratory tracts. Curr Top Microbiol Immunol 1994; 186:177-98.
7. Snijders P, Van den Brule A, Meijer C, et al. HPV and cancer of the aerodigestive tract. Papillomavirus Rep 1995;6:157-62.
8. Franceschi S, Munoz N, Bosch XF, et al. Human papillomavirus and cancers of the upper aerodigestive tract: a review of epidemiological and experimental evidence. Cancer Epidemiol Biomarkers Prev 1996;5:567-75.
9. Newell GR, Krementz ET, Roberts D. Excess occurrence of cancer of the oral cavity, lung, and bladder following cancer of the cervix. Cancer 1975;36:2155-8.
10. Munoz N, Cardis E, Teuchmann S. Comparative epidemiological aspects of orogenital cancers. In: Monsonego J, editor. Papillomaviruses in human pathology. Recent progress in epidermoid precancers. New York: Serono Symposia Publications, Raven Press, 1990;78:1-12.
11. Day NE, Boice JD. Second cancer in relation to radiation treatment for cervical cancer. IARC Scientific Publications. Lyon, IARC 1983;52:818-24.
12. Boice JD, Day NE, Andersen A, et al. Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J Natl Cancer Inst 1985;74:955-75.
13. Storm HH, Jensen OR, Ewertz M, et al. Summary: multiple primary cancers in Denmark, 1943-1980. Monogr Natl Cancer Inst 1985;68:411-30.
14. Teppo I, Pukkala E, Saxen E. Multiple cancer: an epidemiologic exercise in Finland. J Natl Cancer Inst 1985;75: 207-11.
15. Rabkin CS, Biggar RJ, Melbye M, et al. Second primary cancers following anal and cervical carcinoma: evidence of shared etiologic factors. Am J Epidemiol 1992;136: 54-8.
16. Bjorge T, Hennig EM, Skare GB, et al. Second primary cancers in patients with carcinoma in situ of the uterine cervix. The Norwegian experience 1970-1992. Int J Cancer 1995;62:29-33.
17. Lee NK, Ritter DB, Gross AE, et al. Head and neck squamous cell carcinomas associated with human papillomaviruses and an increased incidence of cervical pathology. Otolaryngol Head Neck Surg 1988;99:296-301.
18. Kellokoski JK, Syrjänen SM, Syrjänen KJ, et al. Oral mucosal changes in women with genital HPV infection. J Oral Pathol Med 1990;19:142-8.
19. Miller C, Zeuss MS, White DK, et al. Detection of HPV DNA in oral carcinoma using polymerase chain reaction together with in situ hybridization. Oral Surg Oral Med Oral Pathol 1994;77:480-6.
20. Chang F, Syrjänen S, Nuutinen J, et al. Detection of human papillomavirus (HPV) DNA in oral squamous cell carcinomas by in situ hybridization and polymerase chain reaction. Arch Dermatol Res 1990;282:493-7.
21. Yeudall WA, Campo MS. Human papillomavirus DNA in biopsies of oral tissues. J Gen Virol 1991;72:173-176.
22. Balaram P, Nalinakumari KR, Abraham E, et al. Human papillomaviruses in 91 oral cancers from Indian betel quid chewers-high prevalence and multiplicity of infections. Int J Cancer 1995;61:450-4.
23. Chang K-W, Chang C-S, Lai K-S, et al. High prevalence of human papillomavirus infection and possible association with betel quid chewing and smoking in oral epidermoid carcinomas in Taiwan. J Med Virol 1989;28:57-61.
24. Anderson JA, Irish JC, McLachlin CM, et al. H-ras oncogene mutation and human papillomavirus infection in oral carcinomas. Arch Otolaryngol Head Neck Surg 1994;120:755-60.
25. Ostwald C, Müller P, Barten M, et al. Human papillomavirus DNA in oral squamous cell carcinomas and normal mucosa. J Oral Pathol Med 1994;23:220-5.
26. Holladay EB, Gerald WL. Viral gene detection in oral neoplasms using the polymerase chain reaction. Am J Clin Pathol 1993;100:36-40.
27. Woods KV, Shillitoe EJ, Spitz MR, et al. Analysis of human papillomavirus DNA in oral squamous cell carcinomas. J Oral Pathol Med 1993;22:101-8.
28. Cruz IBF, Snijders PJF, Steenbergen RDM, et al. Age-dependence of human papillomavirus DNA presence in oral squamous cell carcinomas. Oral Oncol Eur J Cancer 1996;32B:55-62.
29. Kashima HK, Kutcher M, Kessis T, et al. Human papillomavirus in squamous cell carcinoma, leukoplakia, lichen planus, and clinically normal epithelium of the oral cavity. Ann Otol Rhinol Laryngol 1990;99:55-61.
30. Brandwein M, Zietlin J, Nuovo GJ, et al. HPV detection using 'hot start' polymerase chain reaction in patients with oral cancer: a clinicopathological study of 64 patients. Modern Pathol 1994;7:720-7.
31. Maitland NJ, Cox MF, Lynas C, et al. Detection of human papillomavirus DNA in biopsies of human oral tissue. Br J Cancer 1987;56:245-50.
32. Shindo M, Sawada Y, Kohgo T, et al. Detection of human papillomavirus DNA sequences in tongue squamous-cell carcinomas using the polymerase chain reaction method. Int J Cancer 1992;50:167-71.
33. Niedobitek G, Pitteroff S, Herbst H, et al. Detection of human papillomavirus type 16 DNA in carcinomas of the palatine tonsil. J Clin Pathol 1990;43:918-21.
34. Snijders PJF, Cromme FV, van den Brule AJC, et al. Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology. Int J Cancer 1992;51:845-50.
35. Salam MA, Rockett J, Morris A. General primer-mediated polymerase chain reaction for simultaneous detection and typing of human papillomavirus DNA in laryngeal squamous cell carcinomas. Clin Otolaryngol 1995;20:84-8.
36. Clayman GL, Stewart MG, Weber RS, et al. Human papillomavirus in laryngeal and hypopharyngeal carcinomas. Arch Otolaryngol Head Neck Surg 1994;120:743-8.
37. Syrjänen S, Syrjänen K. Mäntyjärvi R, et al. Human papillomavirus DNA in squamous cell carcinomas of the larynx demonstrated by in situ DNA hybridization. ORL 1987;49:175-86.
38. Anwar K, Nakakuki K, Naiki H, et al. ras gene mutations and HPV infection are common in human laryngeal carcinoma. Int J Cancer 1993;53:22-8.
39. Brandwein MS, Nuovo GJ, Biller H. Analysis of prevalence of human papillomavirus in laryngeal carcinomas. Study of 40 cases using polymerase chain reaction and consensus primers. Ann Otol Rhinol Laryngol 1993;102: 309-13.
40. Hoshikawa T, Nakajima T, Uhara H, et al. Detection of human papillomavirus DNA in laryngeal squamous cell carcinomas by polymerase chain reaction. Laryngoscope 1990;100:647-50.
41. Gorgoulis V, Rassidakis G, Karameris A, et al. Expression of p53 protein in laryngeal squamous cell carcinoma and dysplasia: possible correlation with human papillomavirus infection and clinicopathological findings. Virchows Archiv 1994;425:481-9.
42. Pérez-Ayala M, Ruiz-Cabello F, Esteban F, et al. Presence of HPV 16 sequences in laryngeal carcinomas. Int J Cancer 1990;46:8-11.
43. Scheurlen W, Stremlau A, Gissmann L, et al. Rearranged HPV16 molecules in an anal and in a laryngeal carcinoma. Int J Cancer 1986;38:671-6.
44. Morgan DW, Abdullah V, Quiney R, et al. Human papilloma virus and carcinoma of the laryngopharynx. J Laryngol Otol 1991;105:288-290.
45. Lindeberg H, Syrjänen S, Kärjä J, et al. Human papillomavirus type 11 DNA in squamous cell carcinomas and pre-existing multiple laryngeal papillomas. Acta Otolaryngol 1989;107:141-9.
46. Kinoshita I, Dosaka-Akita H, Shindoh M, et al. Human papillomavirus type 18 DNA and E6-E7 mRNA are detected in squamous cell carcinoma and adenocarcinoma of the lung. Br J Cancer 1995;71:344-9.
47. Szabo I, Sepp R, Nakamoto K, et al. Human papillomavirus not found in squamous and large cell lung carcinomas by polymerase chain reaction. Cancer 1994;73: 2740-4.
48. Béjui-Thivolet F, Liagre N, Chignol MC, et al. Detection of human papillomavirus DNA in squamous bronchial metaplasia and squamous cell carcinomas of the lung by in situ hybridization using biotinylated probes in paraffin-embedded specimens. Human Pathol 1990;21:111-6.
49. Yousem SA, Ohori NP, Sonmez-Alpan E. Occurrence of human papillomavirus DNA in primary lung neoplasms. Cancer 1991;69:693-7.
50. Shamanin V, Delius H, De Villiers E-M. Development of a broad spectrum PCR assay for papillomaviruses and its application in screening lung cancer biopsies. J Gen Virol 1994;75:1149-56.
51. Syrjänen KJ, Syrjänen SM. Human papillomavirus DNA in bronchial squamous cell carcinomas. Lancet 1987;1: 168-9.
52. Fong KM, Schonrock J, Frazer IM, et al. Human papillomavirus not found in squamous and large cell lung carcinomas by polymerase chain reaction. Cancer 1995;75: 2400-1.
53. Loke SL, Ma L, Wong M, et al. Human papillomavirus in oesophageal squamous cell carcinoma. J Clin Pathol 1990;43:909-12.
54. Togawa K, Jaskiewicz K, Takahashi H, et al. Human papillomavirus DNA in esophagus squamous cell carcinoma. Gastroenterology 1994;107:128-36.
55. Ton Y, Kuwano H, Tanaka S, et al. Detection of human papillomavirus DNA in esophageal carcinoma in Japan by polymerase chain reaction. Cancer 1992;70:2234-8.
56. Kulski J, Demeter T, Sterrett GF, et al. Human papilloma virus in oesophageal carcinoma. Lancet 1986;2:683-4.
57. Furihata M, Ohtsuki Y, Ogoshi, et al. Prognostic significance of human papillomavirus genomes (type-16, -18) and aberrant expression of p53 protein in human esophageal cancer. Int J Cancer 1993;54:226-30.
58. Poljak M, Cerar A. Human papillomavirus type 16 in oesophageal squamous cell carcinoma. Anticancer Res 1993;13:2113-6.
59. Chen B, Yin H, Dhurandhar N. Detection of human papillomavirus DNA in esophageal squamous cell carcinomas by the polymerase chain reaction using consensus primers. Hum Pathol 1994;25:920-3.
60. Akutsu N, Shirasawa H, Nakano K, et al. Rare association of human papillomavirus DNA with esophageal cancer in Japan. J Infect Dis 1995;171:425-8.
61. Cooper K, Taylor L, Govind S. Human papillomavirus DNA in oesophageal carcinomas in South Africa. J Pathol 1995;175:273-7.
62. Smits HL, Tjong-A-Hung SP, ter Schegget J, et al. Absence of human papillomavirus DNA from esophageal carcinoma as determined by multiple broad spectrum polymerase chain reactions. J Med Virol 1995;46:213-5.
63. Chang F, Syrjänen S, Wang SL, et al., Human papillomavirus involvement in esophageal precancerous lesions and squamous cell carcinomas as evidenced by microscopy and different DNA techniques. Scand J Gastroenterol 1992;27:553-63.
64. Benamouzig R, Pigot F, Quiroga G, et al. Human papillomavirus infection in esophageal squamous-cell carcinoma in Western countries. Int J Cancer 1992;50:549-52.
65. Williamson A-I, Jaskiesicz K, Gunning A. The detection of human papillomavirus in oesophageal lesions. Anti-cancer Res 1991;11:263-6.
66. Chang F, Syrjänen S, Shen Q, et al. Screening for human papillomavirus infections in esophageal squamous cell carcinomas by in situ hybridization. Cancer 1993;72: 2525-30.
67. Byrne JC, Tsao M-S, Fraser RS, et al. Human papillomavirus 11 DNA in a patient with chronic laryngotracheobronchial papillomatosis and metastatic squamous-cell carcinoma of the lung. N Engl J Med 1987;317:873-8.
68. Zarod AP, Rutherford JD, Corbitt G, et al. Malignant progression of laryngeal papilloma associated with human papilloma virus type 6 (HPV-6) DNA. J Clin Pathol 1988:44:280-3.
69. McCullough DW, McNicol PJ. Laryngeal carcinoma associated with human papillomavirus type 16. J Otolaryngol 1991;20:97-9.
70. DiLorenzo TP, Tamsen A, Abramson AL, et al. Human papillomavirus type 6a DNA in the lung carcinoma of a patient with recurrent laryngeal papillomatosis is characterized by a partial duplication. J Gen Virol 1992;73: 423-8.
71. Brachman DG, Graves D, Vokes E, et al. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res 1992;52: 4832-6.
72. Lewensohn-Fuchs I, Munck-Wikland E, Berke Z, et al. Involvement of aberrant p53 expression and human papillomavirus in carcinoma of the head, neck, and esopha gus. Anticancer Res 1994;14:1281-6.
73. Fouret P, Martin F, Flahault A, et al. Human papillomavirus infection in the malignant and premalignant head and neck epithelium. Diagn Mol Pathol 1995;4:122-7.
74. Snijders PJF, Scholes AGM, Hart CA, et al. Prevalence of mucosotropic human papillomaviruses in squamous-cell carcinomas of the head and neck. Int J Cancer 1996;66: 464-9.
75. Brandsma JL, Abramson AL. Association of papillomavirus with cancers of the head and neck. Arch Otolaryngol Head Neck Surg 1989;115:621-5.
76. Bosch FX, Manos M, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
77. Daling JR, Sherman KJ. Relationship between human papillomavirus infection and tumours of anogenital sites other than the cervix. In: Munoz N, Bosch FX, Shah KV, Meheus, editors. The epidemiology of cervical cancer and human papillomavirus. Lyon, IARC 1992:223:41.
78. Broby C, Storey A, McGregor J, et al. Does human papillomavirus infection play a role in non-melanoma skin cancer? Papillomavirus Rep 1996;7:53-60.
79. Kahn T, Schwarz E, zur Hausen H. Molecular cloning and characterization of the DNA of a new human papillomavirus (HPV 30) from a laryngeal carcinoma. Int J Cancer 1986;37:61-5.
80. Chang F, Syrjänen S, Syrjänen K. Demonstration of human papillomavirus (HPV) type 30 in esophageal squamous-cell carcinomas by in situ hybridization. Int J Cancer 1993;55:171-3.
81. Togawa K, Rustgi AK. A novel human papillomavirus sequence based on L1 general primers. Virus Res 1995; 36:293-7.
82. Volter C, He Y, Delius H, et al. Novel HPV types present in oral papillomatous lesions from patients with HIV infection. Int J Cancer 1996;66:453-6.
83. Maden C, Beckmann AM, Thomas DB, et al. Human papillomaviruses, herpes simplex viruses, and the risk of oral cancer in men. Am J Epidemiol 1992;135:1093-102.
84. Dillner J, Knekt P, Schiller JT, et al. Prospective seroepidemiological evidence that human papillomavirus type 16 infection is a risk factor for oesophageal squamous cell carcinoma. Br Med J 1995;311:1346.
85. Syrjänen S, Syrjänen K, Happonen R-P. Human papillomavirus (HPV) DNA sequences in oral precancer lesions and squamous cell carcinoma demonstrated by in situ hybridization. J Oral Pathol 1988;17:273-8.
86. Shroyer KR, Greer RO, Fankhouser CA, et al. Detection of human papillomavirus DNA in oral verrucous carcinoma by polymerase chain reaction. Modern Pathol 1993;6:669-72.
87. Steenbergen RDM, Hermsen MAJA, Walboomers JMM, et al. Integrated human papillomavirus type 16 and loss of heterozygosity at Hq22 and 18q21 in an oral carcinoma and its derivative cell line. Cancer Res 1995;55: 5465-71.
88. Simon M, Kahn T, Schneider A, et al. Laryngeal carcinoma in a 12-year-old child. Arch Otolaryngol Head Neck Surg 1994;120:277-82.
89. Bercovich JA, Centeno CR, Aguilar OG, et al. Presence and integration of human papillomavirus type 6 in a tonsillar carcinoma. J Gen Virol 1991;72:2569-72.
90. Kahn T, Turazza E, Ojeda R, et al. Integration of human papillomavirus type 6a DNA in a tonsillar carcinoma: chromosomal localization and nucleotide sequence of the genomic target region. Cancer Res 1994;54:1305-12.
91. Bradford CR, Zacks SE, Androphy EJ, et al. Human papillomavirus DNA sequences in cell lines derived from head and neck squamous cell carcinomas. Otolaryngol Head Neck Surg 1991;104:303-10.
92. Dillon L, Sacks P, Adler-Storthz K. Human papillomavirus DNA sequences in head and neck tumor cell lines. J Dent Res 1990;269:151.
93. Wong DY, Chang KW, Chen CF, et al. Characterization of two new cell lines derived from oral cavity human squamous cell carcinomas, OC1and OC2. Oral Maxillofac Surg 1990;48:385-90.
94. Yeudall WA, Paterson IC, Patel V, et al. Presence of human papillomavirus sequences in tumour-drived human oral keratinocytes expressing mutant p53. Oral Oncol Eur J Cancer 1995;31B:136-43.
95. Li Y-Q, Witte D, Myer CM, et al. Involvement of episomal HPV31 in a laryngeal carcinoma: persistent episomal maintenance of HPV DNA after passage through nude mice. Int J Oncol 1994;4:1377-82.
96. Park NH, Min BM, Li SL, et al. Immortalization of normal human oral keratinocytes with type 16 human papillomavirus. Carcinogenesis 1991;12:1627-31.
97. Sexton CJ, Proby CM, Banks L, et al. Characterization of factors involved in human papillomavirus type 16-mediated immortalization of oral keratinocytes. J Gen Virol 1993;74:755-61.
98. Shin K-H, Min B-M, Cherrick HM, et al. Combined effects of human papillomavirus-18 and N-methyl-N′-nitro-N-nitrosoguanidine on the transformation of normal human oral keratinocytes. Mol Carcinogen 1994;9: 76-86.
99. Zur Hausen H. Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix. Lancet 1994;343:955-7.
100. Steenbergen RDM, Walboomers JMM, Meijer CJLM, et al. Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: activation of telomerase and allele losses at 3p, 10p, 11q and/or 18q. Oncogene 1996;13:1249-57.
101. Willey JC, Broussoud A, Sleemi A, et al. Immortalization of normal human bronchial epithelial cells by human papillomavirus 16 and 18. Cancer Res 1991;51:5370-7.
102. Viallet J, Liu C, Emond J, et al. Characterization of human bronchial epithelial cells immortalized by the E6 and E7 genes of human papillomavirus type 16. Exp Cell Res 1994;212:36-41.
103. De Silva R, Whitaker NJ, Rogan EM, et al. HPV-16 E6 and E7 genes, like SV40 early region genes, are insufficient for immortalization of human mesothelial and bronchial epithelial cells. Exp Cell Res 1994;213:418-27.
104. Debiec-Richter M, Zukowski K, Wang CY, et al. Chromosomal characterizations of human nasal and nasopharyngeal cells immortalized by human papillomavirus type 16 DNA. Cancer Genet Cytogenet 1991;52:51-61.
105. Steele C, Sacks PG, Adler-Storthz K, et al. Effect on cancer cells of plasmids that express antisense RNA of human papillomavirus type 18. Cancer Res 1992;52:4706-11.
106. Bosch FX, Munoz N, de Sanjose S, et al. What is relevant in cervical carcinogenesis other than HPV? In: Monsonego J, editor. Challenges of modern medicine: papillomavirus in human pathology. Rome: Ares-Serono Symposia, 1995;9:173-81.
107. Stanley M, Sarkar S. Genetic changes in cervical carcinoma. Papillomavirus Rep 1994;5:141-7.
108. Mullokandov MR, Kholodilov NG, Atkin NB, et al. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papillomavirus status. Cancer Res 1996;56:197-205.
109. Heselmeyer K, Schröck E, Du Manoir S, et al. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA 1996;93:479-84.
110. Hermsen MAJA, Joenje H, Arwert F, et al. Centromeric breakage as a major cause of cytogenetic abnormalities in oral squamous cell carcinomas. 1996;15:1-9.
111. Snijders PJF, Steenbergen RDM, Top B, et al. Analysis of p53 status in tonsillar carcinomas associated with human papillomavirus. J Gen Virol 1994;75:2769-75.
112. Chang F, Syrjänen S, Tervahauta A, et al. Frequent mutations of p53 gene in oesophageal squamous cell carcinomas with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis. Br J Cancer 1994;70:346-52.